Guidance on evaluation fees for human drugs and disinfectants: Overview

Health Canada has recently updated the Guidance document on fees for the review of human and disinfectant drug submissions and applications. The revised guidance takes effect on March 19, 2021.

Data and Resources

Additional Info

Field Value
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward